Loss of synaptic connectivity, particularly in second order neurons is a key feature of diabetic retinal neuropathy in the Ins2Akita mouse

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Hombrebueno, Jose R ^a   Chen, Mei ^a   Penalva, Rosana G ^a   Xu, Heping ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLYCINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; CONNECTOME; CONTROLLED STUDY; DARK ADAPTATION; DIABETES MELLITUS; DIABETIC RETINAL NEUROPATHY; ELECTRORETINOGRAM; MALE; MOUSE; MOUSE MODEL; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OSCILLATORY POTENTIAL; RETINA; RETINA AMACRINE CELL; RETINA BIPOLAR GANGLION CELL; RETINA CONE; RETINA DEGENERATION; RETINA GANGLION CELL; RETINA HORIZONTAL NERVE CELL; RETINA OUTER MOLECULAR LAYER; RETINA ROD; SYNAPTIC TRANSMISSION; ANIMAL; COMPLICATION; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; RETINA NERVE CELL; SYNAPSE; TIME;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; MALE; MICE; RETINAL NEURONS; SYNAPSES; TIME FACTORS;

EID: 84901320699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097970     Document Type: Article

References (48)

1. Klein BE (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179-83
2. Lieth E, Gardner TW, Barber AJ, Antonetti DA, Penn State Retina Research Group (2000) Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 28:3-8 (Pubitemid 30433242)
3. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW (2002) Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2:S253-62 (Pubitemid 36351245)
4. Antonetti DA, Lieth E, Barber AJ, Gardner TW (1999) Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol 14:240-8 (Pubitemid 30061167)
5. Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, et al. (2007) Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48:5257-65 (Pubitemid 351260939)
6. Wolter JR (1961) Diabetic retinopathy. Am J Ophthalmol 51:1123-41
7. Bloodworth JM Jr (1962) Diabetic retinopathy. Diabetes 11:1-22
8. Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52:1156-63
9. Barber AJ (2003) A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 27:283-90
10. Ramsey DJ, Ripps H, Qian H (2006) An electrophysiological study of retinal function in the diabetic female rat. Invest Ophthalmol Vis Sci 47:5116-24 (Pubitemid 46586419)
11. Roy MS, Gunkel RD, Podgor MJ (1986) Color vision defects in early diabetic retinopathy. Arch Ophthalmol 104:225-8 (Pubitemid 16119619)
12. Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C (1988) The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology 95:693-8.
13. Park SH, Park JW, Park SJ, Kim KY, Chung JW, et al. (2003) Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 46:1260-8.
14. Szabadfi K, Atlasz T, Kiss P, Reglodi D, Szabo, et al. (2012) Protective effects of the neuropeptide PACAP in diabetic retinopathy. Cell Tissue Res 348:37-46
15. Ozawa Y, Kurihara T, Sasaki M (2011) Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model. Exp Diabetes Res 2011:108328
16. Preet A, Siddiqui MR, Taha A, Badhai J, Hussain ME, et al. (2006) Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biochemical abnormalities in diabetic rat ocular tissues. Mol Cell Biochem 289:137-47 (Pubitemid 44322483)
17. Gastinger MJ, Kunselman AR, Conboy EE, Bronson SK, Barber AJ (2008) Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. Invest Ophthalmol Vis Sci 49:2635-42
18. Gastinger MJ, Singh RS, Barber AJ (2006) Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 47:3143-50 (Pubitemid 351639794)
19. Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, et al. (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210-8
20. Han Z, Guo J, Conley SM, Naash MI (2013) Retinal angiogenesis in the Ins2 (Akita) mouse model of diabetic retinopathy. Invest Ophthalmol Vis Sci 54:574-84
21. Yoshioka M, Kayo T, Ikeda T, Koizumi A (1997) A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46:887-94 (Pubitemid 27188269)
22. Paques M, Guyomard JL, Simonutti M, Roux MJ, Picaud S, et al. (2007) Panretinal, high-resolution color photography of the mouse fundus. Invest Ophthalmol Vis Sci 48:2769-74. (Pubitemid 351261232)
23. Xu H, Koch P, Chen M, Lau A, Reid DM, et al. (2008) A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp Eye Res 87:319-26
24. Hombrebueno JR, Luo C, Guo L, Chen M, Xu H (2014) Intravitreal Injection of Normal Saline Induces Retinal Degeneration in the C57BL/6J Mouse. Trans Vis Sci Tech 3:3
25. Knott EJ, Sheets KG, Zhou Y, Gordon WC, Bazan NG (2011) Spatial correlation of mouse photoreceptor-RPE thickness between SD-OCT and histology. Exp Eye Res 92:155-60
26. Hombrebueno JR, Tsai MM, Kim HL, De Juan J, Grzywacz NM, et al. (2010) Morphological changes of short-wavelength cones in the developing S334ter-3 transgenic rat. Brain Res 1321:60-6
27. Chen M, Hombrebueno JR, Luo C, Penalva R, Zhao J, et al. (2013) Age- and light-dependent development of localised retinal atrophy in CCL2(-/-) CX3CR1(GFP/GFP) mice. PLoS One 8:e61381
28. Vaney DI, Young HM (1988) GABA-like immunoreactivity in cholinergic amacrine cells of the rabbit retina. Brain Res 438:369-73 (Pubitemid 18016847)
29. Rice DS, Curran T (2000) Disabled-1 is expressed in type AII amacrine cells in the mouse retina. J Comp Neurol 424:327-38 (Pubitemid 30616994)
30. Vagaja NN, Binz N, McLenachan S, Rakoczy EP, McMenamin PG (2013) Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice. Br J Ophthalmol 97:1343-50
31. McLenachan S, Chen X, McMenamin PG, Rakoczy EP (2013) Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina. Clin Experiment Ophthalmol 41:582-92
32. Smith SB, Duplantier J, Dun Y, Mysona B, Roon P, et al. (2008) In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. Invest Ophthalmol Vis Sci 49:4154-61
33. Murray AR, Chen Q, Takahashi Y, Zhou KK, Park K, et al. (2013) MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model. Invest Ophthalmol Vis Sci 54:1689-97
34. Carter-Dawson LD, LaVail MM (1979) Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopy. J Comp Neurol 188:245-62 (Pubitemid 10193123)
35. Carter-Dawson LD, LaVail MM (1979) Rods and cones in the mouse retina. II. Autoradiographic analysis of cell generation using tritiated thymidine. J Comp Neurol. 188:263-72 (Pubitemid 10193124)
36. Chen H, Zhang M, Huang S, Wu D (2008) The photopic negative response of flash ERG in nonproliferative diabetic retinopathy. Doc Ophthalmol 117:129-35
37. Tregear SJ, Knowles PJ, Ripley LG, Casswell AG (1997) Chromatic-contrast threshold impairment in diabetes. Eye (Lond) 11:537-46. (Pubitemid 27434990)
38. Kurtenbach A, Mayser HM, Jägle H, Fritsche A, Zrenner E (2006) Hyperoxia, hyperglycemia, and photoreceptor sensitivity in normal and diabetic subjects. Vis Neurosci 23651-61
39. VanGuilder HD, Brucklacher RM, Patel K, Ellis RW, Freeman WM, et al. (2008) Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina. Eur J Neurosci 28:1-11
40. Gao W, Tátrai E, Ölvedy V, Varga B, Laurik L, et al. (2011) Investigation of changes in thickness and reflectivity from layered retinal structures of healthy and diabetic eyes with optical coherence tomography. J Biomed Sci Eng 4:657-665
41. Kowluru RA, Chan PS (2007) Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007:43603
42. Kamal A, Biessels GJ, Ramakers GM, Hendrik Gispen W (2005) The effect of short duration streptozotocin-induced diabetes mellitus on the late phase and threshold of long-term potentiation induction in the rat. Brain Res 1053:126-30 (Pubitemid 41116797)
43. Yamato T, Misumi Y, Yamasaki S, Kino M, Aomine M (2004) Diabetes mellitus decreases hippocampal release of neurotransmitters: an in vivo microdialysis study of awake, freely moving rats. Diabetes Nutr Metab 17:128-36 (Pubitemid 39117272)
44. Seki M, Tanaka T, Nawa H, Usui T, Fukuchi T, et al. (2004) Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 53:2412-9 (Pubitemid 39145597)
45. Wachtmeister L, Dowling JE (1978) The oscillatory potentials of the mudpuppy retina. Invest Ophthalmol Vis Sci 17:1176-88 (Pubitemid 9030522)
46. Wachtmeister L (1998) Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17:485-521
47. Tzekov R, Arden GB (1999) The electroretinogram in diabetic retinopathy. Surv Ophthalmol 44:53-60. (Pubitemid 29378353)
48. Ishikawa A, Ishiguro S, Tamai M (1996) Changes in GABA metabolism in streptozotocin-induced diabetic rat retinas. Curr Eye Res 15:63-71. (Pubitemid 26045765)